ArticleCellular oncology (Dordrecht, Netherlands)2019

Clinical significance of metabolism-related biomarkers in non-Hodgkin lymphoma - MCT1 as potential target in diffuse large B cell lymphoma.

Julieta Afonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.